Long-term cause-specific mortality among survivors of childhood cancer

JAMA : the Journal of the American Medical Association
R C ReulenBritish Childhood Cancer Survivor Study Steering Group

Abstract

Survivors of childhood cancer are at increased risk of premature mortality compared with the general population, but little is known about the long-term risks of specific causes of death, particularly beyond 25 years from diagnosis at ages when background mortality in the general population starts to increase substantially. To investigate long-term cause-specific mortality among 5-year survivors of childhood cancer in a large-scale population-based cohort. British Childhood Cancer Survivor Study, a population-based cohort of 17,981 5-year survivors of childhood cancer diagnosed with cancer before age 15 years between 1940 and 1991 in Britain and followed up until the end of 2006. Cause-specific standardized mortality ratios (SMRs) and absolute excess risks (AERs). Overall, 3049 deaths were observed, which was 11 times the number expected (SMR, 10.7; 95% confidence interval [CI], 10.3-11.1). The SMR declined with follow-up but was still 3-fold higher than expected (95% CI, 2.5-3.9) 45 years from diagnosis. The AER for deaths from recurrence declined from 97 extra deaths (95% CI, 92-101) per 10,000 person-years at 5 to 14 years from diagnosis, to 8 extra deaths (95% CI, 3-22) beyond 45 years from diagnosis. In contrast, during th...Continue Reading

Associated Clinical Trials

Citations

Dec 24, 2013·Current Opinion in Pediatrics·Pamela Kearns, Bruce Morland
Aug 9, 2012·Future Cardiology·Danielle HarakeSteven E Lipshultz
Sep 30, 2014·International Journal of Environmental Research and Public Health·Evelyn WinterTânia B Creckzynski-Pasa
Apr 30, 2013·Journal of Cancer Survivorship : Research and Practice·E SieswerdaL C M Kremer
May 7, 2014·Neuro-oncology·Ryan Koshy MathewPaul Dominic Chumas
Sep 26, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sebastiaan L KnijnenburgMonique W Jaspers
Apr 22, 2014·Current Treatment Options in Cardiovascular Medicine·Shashi RajSteven E Lipshultz
Aug 24, 2013·Archives of Disease in Childhood·Adam GlaserUNKNOWN Children and Young People workstream of the National Cancer Survivor Initiative (NCSI), UK
Feb 19, 2011·Cardiology Research and Practice·Vivian I FrancoSteven E Lipshultz
Jun 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory T ArmstrongLeslie L Robison
Sep 29, 2011·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Gill Levitt
Feb 9, 2012·Journal of the National Cancer Institute·Lois B TravisJohn D Boice
Jun 28, 2012·International Journal of Epidemiology·Claudia E KuehniUNKNOWN Swiss Paediatric Oncology Group (SPOG)
Oct 6, 2012·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Ellen RuudSophie Dorothea Fosså
Oct 12, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Stuart L Goldstein, Prasad Devarajan
May 20, 2011·Nature Reviews. Cancer·Wayne D Newhauser, Marco Durante
Oct 12, 2012·Nature Reviews. Cancer·Robin E Norris, Peter C Adamson
Mar 27, 2013·Paediatric Drugs·Shahrad Rod RassekhMichael R Hayden
Mar 30, 2012·Journal of Cardiovascular Translational Research·Daniel A MulrooneyDaniel Duprez
Jan 12, 2011·Pediatric Cardiology·Barry H TrachtenbergSteven E Lipshultz
Jan 1, 2014·Health Physics·Lois B TravisJohn D Boice
Oct 30, 2013·Nature Reviews. Clinical Oncology·Steven E LipshultzTracie L Miller
Jul 18, 2012·European Heart Journal Cardiovascular Imaging·Wei YuYiu-fai Cheung
Nov 29, 2012·Cancer Causes & Control : CCC·Emily S TonorezosKevin C Oeffinger
Nov 14, 2012·Expert Review of Hematology·Kate A O'NeillMichael F G Murphy
Mar 31, 2015·Acta Oncologica·Jeanette F WintherMike M Hawkins
Jan 15, 2015·Annual Review of Medicine·Steven E LipshultzStephen E Sallan
Jan 7, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R L MulderE Frey
Jun 4, 2013·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Hong-kui YuYiu-fai Cheung
Dec 25, 2012·Mechanisms of Ageing and Development·Luigi A NastoNam V Vo
Aug 25, 2012·The American Journal of Cardiology·Tomas G NeilanRaymond Y Kwong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

The New England Journal of Medicine
Kevin C OeffingerChildhood Cancer Survivor Study
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Gregory T ArmstrongAnn C Mertens
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Lisa DillerCharles A Sklar
© 2021 Meta ULC. All rights reserved